Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 5:08 pm Sale | 2021-02-11 | 13D | Aprea Therapeutics, Inc. APRE | 5AM Ventures IV L.P. | 30,958 13.000% | -37,925 (-55.06%) | Filing History |
| 2021-02-16 4:06 pm Sale | 2020-12-31 | 13G | Aprea Therapeutics, Inc. APRE | Redmile Group, LLC | 63,436 5.990% | -50,000 (-44.08%) | Filing History |
| 2021-02-16 07:32 am Sale | 2020-12-31 | 13G | Aprea Therapeutics, Inc. APRE | Versant Ventures V LLC | 58,777 5.500% | -67,189 (-53.34%) | Filing History |
| 2021-02-16 06:51 am Sale | 2020-12-31 | 13G | Aprea Therapeutics, Inc. APRE | KDev Investments AB | 89,035 8.400% | -33,207 (-27.17%) | Filing History |
| 2021-02-12 4:17 pm Sale | 2020-12-31 | 13G | Aprea Therapeutics, Inc. APRE | SECTORAL ASSET MANAGEMENT INC | 8,184 0.770% | -65,333 (-88.87%) | Filing History |
| 2021-02-11 2:23 pm Sale | 2020-12-31 | 13G | Aprea Therapeutics, Inc. APRE | JANUS HENDERSON GROUP PLC JHG | 0 0.000% | -90,543 (Position Closed) | Filing History |
| 2021-02-10 09:23 am Sale | 2021-02-09 | 13G | Aprea Therapeutics, Inc. APRE | FMR LLC | 1 0.000% | -63,063 (-100.00%) | Filing History |
| 2021-02-08 10:15 am Sale | 2021-02-05 | 13G | Aprea Therapeutics, Inc. APRE | FMR LLC | 63,064 5.953% | -44,057 (-41.13%) | Filing History |